Feedback / Questions
AHB-137 - Ausper Biopharma
https://www.prnewswire.com/news-releases/ausperbio-reaches-key-milestone-with-dosing-completion-and-study-unblinding-in-ongoing-ahb-137-phase-iib-trial-302373308.html
Feb 11, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next